NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,352,803 | +1.5% | 13,281 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $1,333,425 | +5.3% | 13,214 | -4.0% | 0.00% | 0.0% |
| Q1 2023 | $1,266,840 | -3.6% | 13,770 | -5.0% | 0.00% | 0.0% |
| Q4 2022 | $1,314,442 | +17.6% | 14,489 | -0.8% | 0.00% | +100.0% |
| Q3 2022 | $1,118,000 | +0.7% | 14,607 | +11.3% | 0.00% | 0.0% |
| Q2 2022 | $1,110,000 | -3.5% | 13,129 | +0.2% | 0.00% | 0.0% |
| Q1 2022 | $1,150,000 | -1.8% | 13,105 | -2.1% | 0.00% | 0.0% |
| Q4 2021 | $1,171,000 | +6.5% | 13,385 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $1,100,000 | -74.1% | 13,451 | -70.7% | 0.00% | -75.0% |
| Q2 2021 | $4,243,000 | +9.2% | 45,929 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $3,886,000 | -3.4% | 45,460 | +6.7% | 0.00% | -20.0% |
| Q4 2020 | $4,023,000 | -17.6% | 42,598 | -24.2% | 0.01% | -28.6% |
| Q3 2020 | $4,885,000 | -63.4% | 56,173 | -63.3% | 0.01% | -63.2% |
| Q2 2020 | $13,361,000 | -5.2% | 152,972 | -10.5% | 0.02% | -20.8% |
| Q1 2020 | $14,090,000 | -7.5% | 170,887 | +6.2% | 0.02% | +9.1% |
| Q4 2019 | $15,236,000 | +8.3% | 160,900 | -0.6% | 0.02% | 0.0% |
| Q3 2019 | $14,071,000 | -6.0% | 161,917 | -1.2% | 0.02% | 0.0% |
| Q2 2019 | $14,966,000 | -7.5% | 163,904 | -2.6% | 0.02% | -12.0% |
| Q1 2019 | $16,185,000 | -5.0% | 168,344 | -15.2% | 0.02% | -16.7% |
| Q4 2018 | $17,041,000 | -3.4% | 198,591 | -3.0% | 0.03% | +15.4% |
| Q3 2018 | $17,649,000 | +24.7% | 204,837 | +9.3% | 0.03% | +18.2% |
| Q2 2018 | $14,152,000 | +4.9% | 187,339 | +12.3% | 0.02% | +4.8% |
| Q1 2018 | $13,489,000 | +2.4% | 166,840 | +6.3% | 0.02% | +10.5% |
| Q4 2017 | $13,172,000 | +9.8% | 156,884 | +12.3% | 0.02% | +5.6% |
| Q3 2017 | $11,994,000 | +18.8% | 139,712 | +15.5% | 0.02% | +12.5% |
| Q2 2017 | $10,094,000 | +75.8% | 120,928 | +56.4% | 0.02% | +77.8% |
| Q1 2017 | $5,741,000 | +107.7% | 77,301 | +103.7% | 0.01% | +80.0% |
| Q4 2016 | $2,764,000 | -13.9% | 37,942 | -6.7% | 0.01% | -16.7% |
| Q3 2016 | $3,210,000 | +6.2% | 40,657 | +11.0% | 0.01% | +20.0% |
| Q2 2016 | $3,022,000 | +21.6% | 36,623 | +6.7% | 0.01% | 0.0% |
| Q1 2016 | $2,486,000 | -48.3% | 34,319 | -38.6% | 0.01% | -50.0% |
| Q4 2015 | $4,806,000 | -1.2% | 55,855 | +5.5% | 0.01% | 0.0% |
| Q3 2015 | $4,866,000 | -7.6% | 52,940 | -1.2% | 0.01% | +11.1% |
| Q2 2015 | $5,269,000 | -7.2% | 53,575 | -6.9% | 0.01% | -10.0% |
| Q1 2015 | $5,678,000 | -27.7% | 57,574 | -32.1% | 0.01% | -23.1% |
| Q4 2014 | $7,858,000 | +58.1% | 84,807 | +60.6% | 0.01% | +44.4% |
| Q3 2014 | $4,969,000 | -22.9% | 52,792 | -25.9% | 0.01% | -18.2% |
| Q2 2014 | $6,447,000 | -12.8% | 71,214 | -18.1% | 0.01% | -15.4% |
| Q1 2014 | $7,391,000 | +25.0% | 86,933 | +18.1% | 0.01% | +18.2% |
| Q4 2013 | $5,915,000 | +7.4% | 73,585 | +2.5% | 0.01% | 0.0% |
| Q3 2013 | $5,506,000 | -12.0% | 71,779 | -18.9% | 0.01% | -15.4% |
| Q2 2013 | $6,255,000 | – | 88,454 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |